Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padova, Italy.
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milano, Italy.
J Thorac Cardiovasc Surg. 2022 Jul;164(1):289-296.e2. doi: 10.1016/j.jtcvs.2021.07.023. Epub 2021 Jul 21.
For small-sized recipients of lung transplantation, the time span for organ reception from standard donors is generally longer than for normal-sized patients. Despite its underuse, lobar reduction may be a concrete option for these patients. This study aims to assess early and long-term outcomes associated with lobar reduction in lung transplantation.
A retrospective study was performed on 608 consecutive lung transplantations at 2 centers between January 2005 and August 2019 (559 standard lung transplantations [standard transplantation] and 49 with lobar reduction [lung transplantation group]). A propensity-score weighting approach was used to account for potential confounding related to patients' nonrandom allocation to the 2 intervention groups. The effects of the intervention on postoperative outcomes were assessed with a weighted regression approach.
The propensity score was estimated on 571 patients (522 in standard transplantation group and 49 in lung transplantation group). In terms of early outcomes, the lung transplantation group showed a higher percentage of severe primary graft dysfunction at 0 hours and reported longer intensive care unit stay than the standard transplantation group. No other differences in terms of morbidity, mortality, mechanical ventilation time, hospital stay, and anastomotic complications were observed. Although the lung transplantation group showed worse long-term pulmonary function, the 2 populations had comparable survival outcomes.
The use of lobar reduction showed early and long-term results comparable to those after standard lung transplantation. Although a higher rate of early severe primary graft dysfunction and slightly reduced respiratory function were detected in the lobar group, these did not affect patients' morbidity and survival.
对于接受肺移植的小受体而言,从标准供体接受器官的时间跨度通常比正常体型患者更长。尽管肺叶切除术的应用并不广泛,但对于这些患者来说,肺叶切除术可能是一种切实可行的选择。本研究旨在评估肺移植中肺叶切除术的早期和长期结果。
对 2005 年 1 月至 2019 年 8 月期间在 2 个中心进行的 608 例连续肺移植(559 例标准肺移植[标准移植]和 49 例肺叶切除术[肺移植组])进行回顾性研究。采用倾向评分加权法来考虑患者非随机分配到 2 个干预组的潜在混杂因素。采用加权回归方法评估干预对术后结果的影响。
对 571 例患者(标准移植组 522 例,肺移植组 49 例)进行了倾向评分估计。就早期结果而言,肺移植组在 0 小时时严重原发性移植物功能障碍的比例较高,并且报告重症监护病房停留时间较长。两组在发病率、死亡率、机械通气时间、住院时间和吻合口并发症方面没有其他差异。尽管肺移植组的长期肺功能较差,但两组的生存结果相似。
使用肺叶切除术的早期和长期结果与标准肺移植相似。尽管在肺叶组中发现了早期严重原发性移植物功能障碍的发生率较高和呼吸功能略有降低,但这些并未影响患者的发病率和生存率。